Begin main content

Reports

We found 5392 result(s)

benralizumab (Fasenra)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: benralizumab
Indications: Asthma, severe eosinophilic

  • Brand Name: Fasenra
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SF0592-000
  • Project Status: Active
  • Submission Type: RequestForAdvice

Tags

Asthma, Asthma, Respiratory

mepolizumab (Nucala)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: mepolizumab
Indications: Asthma, severe eosinophilic

  • Brand Name: Nucala
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SF0593-000
  • Project Status: Active
  • Submission Type: RequestForAdvice

Tags

Asthma, Asthma, Respiratory

reslizumab (Cinqair)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: reslizumab
Indications: Asthma, eosinophilic

  • Brand Name: Cinqair
  • Manufacturer: TEVA Canada Innovation
  • Project Number: SF0591-000
  • Project Status: Active
  • Submission Type: RequestForAdvice

Tags

Asthma, Asthma, Respiratory

filgrastim (TBC)

Last Updated: December 11, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: filgrastim
Indications: Prevention or treatment of neutropenia in various indications

  • Brand Name: TBC
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SE0585-000
  • Project Status: Active
  • Submission Type: New

Tags

Blood, Cancer, Pediatrics, Blood, Cancer, HIV/AIDS, Pediatrics

edaravone (Radicava)

Last Updated: February 14, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: edaravone
Indications: amyotrophic lateral sclerosis

  • Brand Name: Radicava
  • Manufacturer: Mitsubishi Tanabe Pharma Corporation
  • Project Number: SR0573-000
  • Project Status: Active
  • Submission Type: New

Tags

Nervous System, Nervous system

insulin degludec + liraglutide (Xultophy)

Last Updated: February 14, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: insulin degludec + liraglutide
Indications: Diabetes mellitus, Type 2

  • Brand Name: Xultophy
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: SR0599-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Diabetes

risankizumab (TBC)

Last Updated: December 13, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: risankizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: TBC
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0583-000
  • Project Status: Active
  • Submission Type: New

Tags

Dermatology, Dermatology

isavuconazole (Cresemba)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: isavuconazole
Indications: Treatment of invasive aspergillosis and mucormycosis

  • Brand Name: Cresemba
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0586-000
  • Project Status: Active
  • Submission Type: New

Tags

Infectious Diseases, Nervous System, Infectious diseases, Nervous system, Respiratory, isavuconazole; isavuconazonium sulfate; isavuconazonium sulphate

cerliponase alfa (Brineura)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: cerliponase alfa
Indications: Neuronal Ceroid Lipofuscinosis Type 2

  • Brand Name: Brineura
  • Manufacturer: Biomarin Pharmaceutical (Canada) Inc.
  • Project Number: SR0574-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Nervous System, Lipid Metabolism Disorders, Genetics, Nervous system, neuronal ceroid lipofuscinosis; neuronal ceroid lipofuscinoses; ceroid storage disease; Batten disease; cln2; Batten diseases; ceroid storage diseases; brineura; cerliponase alfa; cerliponase alpha